RESUMO
The aim of this work was to study the ability of some estrogen 8α-analogues, that have CH3-group in the C-3 position, exhibit osteoprotective and cholesterolemic effects. The properties of these analogues was comparisoned with effects of native estradiol and 17α-ethynylestradiol (EE). We showed that compounds 3 ((d,l)-17ß-acethoxy-3-methoxy-8α-estra-1,3,5(10)-triene) and 4 ((d,l)-3-methoxy-8α-estra-1,3,5(10)-triene-17-one) had the same osteoprotective and cholesterolemic effects as EE. The utherotropic effects of compound 3 and EE were the same, while the utherotropic activity of 17-keto derivative (compound 4) was higher than effect of EE. The osteoprotective and cholesterolemic effects of compounds 5 and 6 (d- or l-17ß-acethoxy-3-methoxy-13-ethyl-8α-gone-1,3,5(10)-triene) were approximately the same, however the utherotropic action of these compounds was different: the compound 5 had significantly lower activity, but the compound 6 had the same effect in comparison with EE. Thus, all studied estrogen 8α-analogues may be used as basic constructions for structural modifications which is necessary as medications with while spectrum of biological properties.
Assuntos
Congêneres do Estradiol , Hipercolesterolemia/tratamento farmacológico , Hipolipemiantes , Osteoporose/tratamento farmacológico , Animais , Congêneres do Estradiol/síntese química , Congêneres do Estradiol/química , Congêneres do Estradiol/farmacologia , Feminino , Hipercolesterolemia/metabolismo , Hipercolesterolemia/patologia , Hipolipemiantes/síntese química , Hipolipemiantes/química , Hipolipemiantes/farmacologia , Osteoporose/metabolismo , Osteoporose/patologia , Ratos , Ratos Sprague-DawleyRESUMO
Homocysteine (HCys), a sulfur-containing amino acid, is formed during the metabolism of methionine. An imbalance between the rate of production and the use of HCys during methionine metabolism can result in an increase in the plasma and urinary levels of HCys. HCys has been shown to be toxic to vascular endothelial cells through several pathways. Many earlier clinical studies have revealed an association between plasma HCys and cardiovascular and other diseases. In contrast, estrogens are suggested to lower the risk of cardiovascular disease. Several studies indicate that estrogen metabolites could be responsible for cardiovascular protection. It has been demonstrated that electrophilic estrogen quinones, E1(E2)-2,3-Q and E1(E2)-3,4-Q, can alkylate DNA as well as form conjugates with glutathione. I hypothesize that estrogen quinones generated in situ by oxidative enzymes, metal ions, or molecular oxygen can interact with HCys to form conjugates. This in turn could lower the levels of toxic HCys as well as quenching the reactive estrogen quinones, resulting in cardiovascular protective effects. To test the feasibility of a protective estrogen-HCys pathway, estrogen quinones were treated with HCys. Tandem mass spectrometry analysis of the assay mixture shows the formation of estrogen-HCys conjugates. Furthermore, incubation of catechol estrogens with myeloperoxidase (MPO) in the presence of HCys resulted in the formation of respective estrogen-HCys conjugates. The identities of estrogen-HCys conjugates in MPO assay extracts were confirmed by comparing them to pure synthesized estrogen-HCys standards. I propose that through conjugation estrogens could chemically regulate HCys levels; moreover these conjugates could be used as potential biomarkers in determining health.
Assuntos
Congêneres do Estradiol/síntese química , Estrogênios de Catecol/química , Estrogênios/química , Homocisteína/química , Quinonas/química , Alquilação , Cardiotônicos/química , Doenças Cardiovasculares , DNA/química , Congêneres do Estradiol/química , Glutationa/química , Homocisteína/biossíntese , Homocisteína/sangue , Espectrometria de Massas , Oxirredução , Peroxidase/metabolismoRESUMO
(Arene)dichloridoruthenium(II) complexes with N-coordinated isonicotinates of androgens (6) and estrogens (9) were prepared and tested for affinity to the estrogen receptor (ERα) and sex hormone binding globulin (SHBG), as well as for cytotoxicity in cancer cells. None of the new complexes bound noticeably to the ER and most of them also bound less strongly to SHBG than the corresponding unmetallated steroids 7. In MTT assays the Ru(p-cymene) complexes 9 of 2-substituted estrones were equally or even more cytotoxic than the metal-free steroids against hormone-dependent (MCF-7 breast and KB-V1 cervix carcinomas) and hormone-independent (518A2 melanoma) cells. The addition of external SHBG to MTT assays lowered the cytotoxicities of the complexes 9 and distinctly more so those of some steroids 7, probably by the way of sequestration and reduction of the cellular uptake. In the absence of SHBG the estrogen complexes 9 were internalized by 518A2 melanoma cells and ruthenated their DNA as quantified by ICP-OES. They also ruthenated salmon sperm DNA but did not change the topology of plasmid DNA in EMSA experiments. In addition, the Ru(p-cymene) complex of 2-ethoxyestrone (9c) was shown to reduce the motility of 518A2 melanoma cells in a wound-healing assay.
Assuntos
Antineoplásicos/farmacologia , Complexos de Coordenação/farmacologia , Congêneres do Estradiol/farmacologia , Ácidos Isonicotínicos/farmacologia , Rutênio , Globulina de Ligação a Hormônio Sexual/metabolismo , Congêneres da Testosterona/farmacologia , Antineoplásicos/síntese química , Antineoplásicos/química , Ligação Competitiva , Linhagem Celular Tumoral , Movimento Celular/efeitos dos fármacos , Proliferação de Células/efeitos dos fármacos , Complexos de Coordenação/síntese química , Complexos de Coordenação/química , Ensaios de Seleção de Medicamentos Antitumorais , Congêneres do Estradiol/síntese química , Congêneres do Estradiol/química , Células HL-60 , Humanos , Concentração Inibidora 50 , Ácidos Isonicotínicos/síntese química , Ácidos Isonicotínicos/química , Estrutura Molecular , Ligação Proteica , Receptores de Estrogênio/metabolismo , Congêneres da Testosterona/síntese química , Congêneres da Testosterona/químicaRESUMO
Long-term use of estrogen supplements by women leads to an increased risk of breast and uterine cancers. Possible mechanisms include metabolism of estradiol and compounds related to tumor-initiating quinones, and ligand-induced activation of the estrogen receptors ERα and ERß which can cause cancer cell proliferation, depending on the ratio of receptors present. One therapeutic goal would be to create a spectrum of compounds of variable potency for ERα and ERß, which are resistant to quinone formation, and to determine an optimum point in this spectrum. We describe the synthesis, modeling, binding affinities, hormone potency, and a measure of quinone formation for a new family of A-CD estrogens, where the A-C bond is formed by ring coupling. Some substituents on the A-ring increase hormone potency, and one compound is much less quinone-forming than estradiol. These compounds span a wide range of receptor subtype selectivities and may be useful in hormone replacement therapy.
Assuntos
Congêneres do Estradiol/síntese química , Estradiol/química , Receptor alfa de Estrogênio/agonistas , Receptor beta de Estrogênio/agonistas , Animais , Ligação Competitiva , Linhagem Celular , Congêneres do Estradiol/química , Congêneres do Estradiol/farmacologia , Flúor/química , Hepatócitos/citologia , Hepatócitos/efeitos dos fármacos , Humanos , Ligantes , Masculino , Modelos Moleculares , Estrutura Molecular , Quinonas/metabolismo , Ratos , Ratos Sprague-Dawley , Elementos de Resposta , Estereoisomerismo , Relação Estrutura-Atividade , Termodinâmica , Ativação Transcricional/efeitos dos fármacosAssuntos
Congêneres do Estradiol/farmacologia , Estrogênios/farmacologia , Animais , Congêneres do Estradiol/síntese química , Congêneres do Estradiol/química , Congêneres do Estradiol/farmacocinética , Antagonistas de Estrogênios/síntese química , Antagonistas de Estrogênios/farmacologia , Estrogênios/síntese química , Estrogênios/química , Feminino , Humanos , Receptores de Estrogênio/efeitos dos fármacos , Moduladores Seletivos de Receptor Estrogênico/síntese química , Moduladores Seletivos de Receptor Estrogênico/farmacologiaRESUMO
Estradiol derivatives bearing HS-, HSCH(2)-, HSCH(2)CH(2)-, MeS-, MeSCH(2)-, MeSCH(2)CH(2)-, or PhCH(2)SCH(2)CH(2)-groups at the 11beta position or an HS-group at the 7alpha position have been synthesized, and their binding affinity to the estrogen receptor (ER) determined. Nearly all of these substituted estrogens retain high binding affinity, and at the 11beta position, the sulfur atom has an effect on ER binding that is similar to that of a carbon atom. These thiol derivatives are promising intermediates for the preparation of a variety of estradiol conjugates. The methyl sulfides, in particular, might potentially be developed as (11)C-labeled agents for imaging ER-positive tumors by positron emission tomography.
Assuntos
Congêneres do Estradiol/síntese química , Estradiol/análogos & derivados , Compostos de Sulfidrila/síntese química , Estradiol/síntese química , Congêneres do Estradiol/química , Estrogênios Conjugados (USP)/síntese químicaAssuntos
Dietilestilbestrol/efeitos adversos , Animais , Anuros , Testes de Carcinogenicidade , Carcinógenos/síntese química , Carcinógenos/química , Carcinógenos/farmacologia , Carcinógenos/toxicidade , Cricetinae , Dietilestilbestrol/síntese química , Dietilestilbestrol/química , Dietilestilbestrol/toxicidade , Cães , Exposição Ambiental/efeitos adversos , Exposição Ambiental/legislação & jurisprudência , Congêneres do Estradiol/efeitos adversos , Congêneres do Estradiol/síntese química , Congêneres do Estradiol/química , Congêneres do Estradiol/toxicidade , Feminino , Guias como Assunto , Haplorrinos , Humanos , Masculino , Camundongos , Modelos Biológicos , Gravidez , RatosRESUMO
The pharmacology and SAR of representative equine estogens is described. 17alpha-Dihydroequilenin was found to prevent bone loss after 5 weeks of oral administration to ovariectomized rats. The stereochemical significance of the D-ring and the C/D ring juncture was investigated with a series of benzothiophene-based equilenin analogues.
Assuntos
Equilina/farmacologia , Congêneres do Estradiol/farmacologia , Animais , Equilina/análogos & derivados , Equilina/síntese química , Equilina/química , Congêneres do Estradiol/administração & dosagem , Congêneres do Estradiol/síntese química , Congêneres do Estradiol/química , Feminino , Modelos Moleculares , Conformação Molecular , Tamanho do Órgão/efeitos dos fármacos , Ovariectomia , Ratos , Estereoisomerismo , Relação Estrutura-Atividade , Útero/anatomia & histologia , Útero/efeitos dos fármacosRESUMO
We have synthesized derivatives of estradiol that are structurally modified to serve as "soft" estrogens and act within a geographically limited area of the body; estrogens without systemic action. We have previously shown with 16alpha-substituted analogues of estradiol that carboxylates proximal to the steroid ring neither bind to the estrogen receptor nor activate estrogen-responsive genes. However, when the carboxylic acid is masked as an ester, they bind to the receptor and stimulate estrogenic responses. Enzymatic hydrolysis through nonspecific esterases can inactivate these estrogens and thereby limit their area of action. Here, we describe our continued studies to design "soft" estrogens by synthesizing carboxylic acid esters of estradiol at the 7alpha-, 11beta-, and 15alpha-positions in the steroid nucleus at which bulky substituents are accommodated by the estrogen receptor. These compounds were tested for estrogen receptor binding (estrogen receptors alpha and beta), stimulation of an estrogen sensitive gene in Ishikawa cells in culture, and as substrates for enzymatic hydrolysis. Likely candidates were tested in in vivo assays for systemic and local estrogenic action. The biological studies showed that regardless of the point of attachment, all of the short-chain carboxylic acids, C-1 to C-3, were devoid of hormonal action, while many of the esters were estrogenic. The site on the steroid nucleus had great influence on hormonal activity and esterase hydrolysis. Formate esters at 7alpha and 15alpha were good estrogens, but lengthening the chain to acetate dramatically decreased hormonal activity. However, the 7alpha-formate esters were not enzymatically hydrolyzed. At 11beta, the acetate (methyl ester) was an effective estrogen, but increasing the chain length to propionate dramatically reduced hormonal activity. In general, the length of the alcohol from methyl to butyl had only a small effect on receptor binding, and as the size of the alcohol increased, so did esterase hydrolysis. One exception was the 11beta-acetate esters where increasing the alcohol moiety from methyl to ethyl eliminated estrogenic activity (Ishikawa cells) without affecting estrogen receptor binding. Several of the esters were tested in vivo, and two, the methyl and ethyl esters of estradiol-15alpha-formate, appeared to have the requisite properties (high local and low systemic activity) of superior "soft" estrogens.
Assuntos
Congêneres do Estradiol/síntese química , Estradiol/análogos & derivados , Estradiol/síntese química , Animais , Ligação Competitiva , Esterases/metabolismo , Ésteres , Estradiol/farmacologia , Congêneres do Estradiol/farmacologia , Receptor alfa de Estrogênio , Receptor beta de Estrogênio , Feminino , Humanos , Técnicas In Vitro , Rim/enzimologia , Ligantes , Camundongos , Microssomos/enzimologia , Tamanho do Órgão/efeitos dos fármacos , Oxirredutases/metabolismo , Ratos , Ratos Sprague-Dawley , Receptores de Estrogênio/metabolismo , Relação Estrutura-Atividade , Células Tumorais Cultivadas , Útero/efeitos dos fármacos , Vagina/enzimologiaRESUMO
Estrogens regulate many biological functions, often acting in a tissue-selective manner. Their tissue-selective action is believed to involve differential estrogen action through the two estrogen receptor (ER) subtypes, ERalpha and ERbeta, as well as differential interaction of the ligand-receptor complexes with promoters and coregulator proteins. In the latter case, selectivity is based on the induction of specific conformations of the ligand-ER complex, conformations that are influenced by the structure of the ligand. Estrogen pharmaceuticals having an ideal balance of tissue-selective activity are being sought for menopausal hormone replacement, breast cancer prevention and therapy, and other actions. To expand on the structural diversity of ER ligands that might show such tissue selectivity, we have prepared a series of diazenes (pyrazines, pyrimidines, and pyridazines) substituted with two to four aryl groups and various short-chain aliphatic substituents. All of the pyrazine and pyrimidines bind to ER, some with high affinity and with a considerable degree of preferential binding to either ERalpha or ERbeta. One pyrimidine and one pyrazine have ERalpha affinity preferences as high as 23 and 9, respectively, and one pyrimidine has an ERbeta affinity preference of 8. The pyridazines, by contrast, are quite polar and have only very low binding affinity for the ER. In cell-based transcription assays, several of the pyrimidines and a pyrazine were found to be considerably more agonistic on ERalpha than on ERbeta. Because these triaryl diazenes have the largest volumes among the ER ligands so far investigated, their high affinity demonstrates the flexibility of the ligand binding pocket of the ERs and its tolerance for large substituents. Thus, these novel heterocyclic ligands expand the repertoire of chemical structures that bind to the estrogen receptor, and they could prove to be useful in elucidating the biological behavior of the two ER subtypes and in forming the basis for new estrogen pharmaceuticals having desirable tissue selectivity.
Assuntos
Congêneres do Estradiol/síntese química , Congêneres do Estradiol/farmacologia , Compostos Heterocíclicos/síntese química , Compostos Heterocíclicos/farmacologia , Receptores de Estrogênio/agonistas , Neoplasias do Endométrio/metabolismo , Receptor alfa de Estrogênio , Receptor beta de Estrogênio , Feminino , Humanos , Indicadores e Reagentes , Ligantes , Espectroscopia de Ressonância Magnética , Piridazinas/síntese química , Piridazinas/farmacologia , Pirimidinas/síntese química , Pirimidinas/farmacologia , Receptores de Estrogênio/biossíntese , Receptores de Estrogênio/genética , Proteínas Recombinantes/efeitos dos fármacos , Relação Estrutura-Atividade , Transcrição Gênica/efeitos dos fármacos , Células Tumorais CultivadasRESUMO
An efficient and practical approach to synthesize moderate to large amounts of 2-methoxyestradiol (2-ME2) is described. The key step in the synthesis is the regioselective introduction of an acetyl group at the C-2 position of estradiol using a zirconium tetrachloride mediated Fries rearrangement carried out on estradiol diacetate. The seven step synthetic procedure readily gave 2-ME2 in 49% overall yield. Application of this method to the synthesis of 2-methoxy-7 alpha-methylestradiol is also described.
Assuntos
Estradiol/síntese química , 2-Metoxiestradiol , Estradiol/análogos & derivados , Estradiol/química , Congêneres do Estradiol/síntese química , Congêneres do Estradiol/química , Estrutura MolecularRESUMO
C2-Alkyl-substituted 1,1-bis(4-hydroxyphenyl)-2-phenylethenes were synthesized and assayed for estrogen receptor binding in a competition experiment with radiolabeled estradiol ([3H]-E2) using calf uterine cytosol. The relative binding affinity decreased with the length of the side chain R = H (3a: 35.2%) > Me (3b: 32.1%) > Et (3c: 6.20%) approximately CH2CF3 (3d: 5.95%) > n-Pr (3e: 2.09%) > Bu (3f: 0.62%). Agonistic and antagonistic effects were evaluated in the luciferase assay with MCF-7-2a cells stably transfected with the plasmid ERE(wtc)luc. All compounds showed high antiestrogenic activity without significant agonistic potency. The comparison of the IC(50) values for the inhibition of E2 (1 nM) documented the dependence of the antagonistic effects on the kind of the side chain: 3a (IC50 = 150 nM), 3b (IC50 = 30 nM), and 3f (IC50 = 500 nM) were weak antagonists, while 3c (IC50 = 15 nM), 3d (IC50 = 9 nM), and 3e (IC50 = 50 nM) were full antiestrogens and antagonized the effect of E2 completely. The most active compound 3d possessed the same antagonistic potency as 4-hydroxytamoxifen (4OHT: IC50= 7 nM) without bearing a basic side chain. 3d as well as all other 1,1-bis(4-hydroxyphenyl)-2-phenylalkenes were not able to influence the proliferation of hormone dependent MCF-7 cells despite the antagonistic mode of action. In this assay tamoxifen (TAM) and 4OHT reduced the cell growth concentration dependent up to T/C(corr) = 15% and 25%, respectively.
Assuntos
Antineoplásicos/síntese química , Congêneres do Estradiol/síntese química , Moduladores de Receptor Estrogênico/síntese química , Receptores de Estrogênio/antagonistas & inibidores , Estilbenos/síntese química , Animais , Antineoplásicos/química , Antineoplásicos/farmacologia , Ligação Competitiva , Bovinos , Divisão Celular/efeitos dos fármacos , Citosol/metabolismo , Congêneres do Estradiol/química , Congêneres do Estradiol/farmacologia , Moduladores de Receptor Estrogênico/química , Moduladores de Receptor Estrogênico/farmacologia , Feminino , Humanos , Técnicas In Vitro , Luciferases/genética , Luciferases/metabolismo , Ensaio Radioligante , Receptores de Estrogênio/agonistas , Receptores de Estrogênio/metabolismo , Estilbenos/química , Estilbenos/farmacologia , Células Tumorais Cultivadas , Útero/ultraestruturaRESUMO
The first time synthesis of 7alpha- and 11beta-nitrile estradiol is described. Reaction of 7alpha-cyano-19-nortestosterone with copper(II)bromide in acetonitrile at room temperature results in aromatization of the A-ring. Treatment of 11beta-cyano-19-nortestosterone-17-one under similar condition does not induce A-ring aromatization but rather results in bromination at the 2beta-position. However A-ring aromatized products are obtained when the latter compound is treated with Ac2O-Py-AcOCl, NBS and HCl.
Assuntos
Congêneres do Estradiol/síntese química , Nandrolona/análogos & derivados , Nitrilas/síntese química , Brometos , Cobre , Estradiol/química , Indicadores e Reagentes , Ligantes , Espectrometria de Massas , Nandrolona/química , Receptores de Estrogênio/efeitos dos fármacosRESUMO
A series of eight halogenated 2,4-diaryl-4H,5H-pyrano[3,2-c]benzopyran-5-ones have been synthesized, characterized and their stereochemistry determined. In a second stage of our work, the reported molecules were tested for their antiproliferative activity on MCF-7 breast carcinoma cells. Pharmacological results were compared with those of diethylstilbestrol (DES), an estrogen, as well as ICI 182,780, a pure antiestrogen. Then, these derivatives were evaluated for their capacity to activate the transcription of a reporter gene and for their affinity for human recombinant estrogen receptors alpha (hER alpha). These results were compared with those of coumestrol, a phytoestrogen structurally close to 2,4-diaryl-4H,5H-pyrano[3,2-c]benzopyran-5-ones, and with RU 58668, a pure antiestrogen. Although these derivatives exhibit a significant antiproliferative activity higher than that of ICI 182,780, neither of them displayed a significant estrogenicity or an affinity for hER alpha. Such results may suggest that their antiproliferative activity is not dependent of an antiestrogenic response.
Assuntos
Antineoplásicos Fitogênicos/síntese química , Antineoplásicos Fitogênicos/farmacologia , Benzopiranos/síntese química , Benzopiranos/farmacologia , Antineoplásicos Fitogênicos/química , Benzopiranos/química , Neoplasias da Mama/tratamento farmacológico , Neoplasias da Mama/patologia , Divisão Celular/efeitos dos fármacos , Sobrevivência Celular/efeitos dos fármacos , Fenômenos Químicos , Físico-Química , Cromatografia em Camada Fina , Cumestrol/farmacologia , Ensaios de Seleção de Medicamentos Antitumorais , Congêneres do Estradiol/síntese química , Congêneres do Estradiol/farmacologia , Receptor alfa de Estrogênio , Feminino , Humanos , Espectroscopia de Ressonância Magnética , Receptores de Estrogênio/efeitos dos fármacos , Receptores de Estrogênio/metabolismo , Espectrofotometria Infravermelho , Células Tumorais CultivadasAssuntos
Congêneres do Estradiol/síntese química , Indóis/síntese química , Animais , Densidade Óssea/efeitos dos fármacos , Linhagem Celular , Congêneres do Estradiol/química , Congêneres do Estradiol/metabolismo , Congêneres do Estradiol/farmacologia , Feminino , Indóis/química , Indóis/metabolismo , Indóis/farmacologia , Modelos Moleculares , Tamanho do Órgão , Ovariectomia , Ensaio Radioligante , Ratos , Relação Estrutura-Atividade , Transfecção , Útero/efeitos dos fármacosRESUMO
We attempted to design analogues of estradiol to act as locally active estrogens without significant systemic action. We synthesized a series of 16alpha-carboxylic acid substituted steroids and their esters and tested their action in several assays of estrogenic action, including estrogen receptor (ER) binding, estrogenic potency in Ishikawa cells (human endometrial carcinoma), rat uterine weight (systemic action), and mouse vaginal reductases (local action). All of the estradiol substituted carboxylic acids (formic, acetic and propionic acids) were devoid of estrogenic action. To the contrary, many of the esters had marked estrogenic potency in the receptor and the Ishikawa assays. The esters of the 16alpha-formic acid series had the highest ER affinity with little difference between the straight-chain alcohol esters (from methyl to n-butyl). However, estrogenic action in the Ishikawa assay decreased precipitously with esters longer than the ethyl ester. This decrease correlated well with the increased rate of esterase hydrolysis of longer esters as determined in incubations with rat hepatic microsomes. The most promising candidates, the methyl, ethyl, and fluoroethyl esters of the formate series, were tested for systemic and local action in the in vivo models. All three, especially the fluoroethyl ester, showed divergence between systemic and local estrogenic action. These metabolically labile estrogens will be extremely useful for the therapeutic treatment of the vaginal dyspareunia of menopause in women for whom systemic estrogens are contraindicated.
Assuntos
Congêneres do Estradiol/síntese química , Estradiol/análogos & derivados , Fosfatase Alcalina/biossíntese , Animais , Ligação Competitiva , Indução Enzimática , Ésteres/química , Ésteres/farmacologia , Estradiol/química , Congêneres do Estradiol/química , Congêneres do Estradiol/farmacologia , Receptor alfa de Estrogênio , Receptor beta de Estrogênio , Feminino , Humanos , Técnicas In Vitro , Camundongos , Microssomos Hepáticos/enzimologia , Tamanho do Órgão , Ovariectomia , Oxirredutases/biossíntese , Ratos , Ratos Sprague-Dawley , Receptores de Estrogênio/metabolismo , Relação Estrutura-Atividade , Células Tumorais Cultivadas , Útero/anatomia & histologia , Útero/efeitos dos fármacos , Útero/metabolismo , Vagina/enzimologiaRESUMO
The goal of selective targeting of enediyne cytotoxins has been investigated using estrogenic delivery vehicles. A series of estrogen-enediyne conjugates were assembled, and affinity for human estrogen receptor [hERalpha] was determined. The most promising candidate induced receptor degradation following Bergman cycloaromatization and caused inhibition of estrogen-induced transcription in T47-D human breast cancer cells.
Assuntos
Alcinos/síntese química , Antineoplásicos Hormonais/síntese química , Sistemas de Liberação de Medicamentos , Congêneres do Estradiol/síntese química , Alcinos/farmacologia , Antineoplásicos Hormonais/metabolismo , Antineoplásicos Hormonais/farmacologia , Neoplasias da Mama/tratamento farmacológico , Divisão Celular/efeitos dos fármacos , Ciclização , Congêneres do Estradiol/metabolismo , Congêneres do Estradiol/farmacologia , Feminino , Regulação Neoplásica da Expressão Gênica/efeitos dos fármacos , Humanos , Receptores Androgênicos/efeitos dos fármacos , Receptores Androgênicos/metabolismo , Receptores de Estrogênio/efeitos dos fármacos , Receptores de Estrogênio/metabolismo , Células Tumorais CultivadasRESUMO
In the search for new agents with estrogenic activity mediated by estrogen receptors (ER), six 6,12-dihydro-1-benzopyrano[3,4-b][1,4]benzothiazin-6-ones 3a-f were synthesized. These compounds were readily prepared by the addition of 2-aminothiophenol 2 to substituted 4-hydroxycoumarin derivatives 1a-e. The estrogenic effect has been evaluated on the proliferation of MCF-7 breast adenocarcinoma cells and the specificity of described compounds was evaluated by the inhibition of their effect by ICI 182,780, an antiestrogenic compound. Among the compounds tested, 6,12-dihydro-3-methoxy-1-benzopyrano[3,4-b][1,4]benzothiazin-6-one 3e and 6,12-dihydro-3-hydroxy-1-benzopyrano[3,4-b][1,4]benzothiazin-6-one 3f exhibited an ER-dependent proliferation and a high binding affinity to ER, but a moderate capacity to activate the transcription of a reporter gene. Their pharmacological profiles are defined by their binding properties and their mechanism of action by computational modelling studies.
Assuntos
Benzopiranos/farmacologia , Neoplasias da Mama/patologia , Congêneres do Estradiol/síntese química , Congêneres do Estradiol/farmacologia , Tiazinas/farmacologia , Benzopiranos/síntese química , Divisão Celular/efeitos dos fármacos , Relação Dose-Resposta a Droga , Feminino , Humanos , Modelos Moleculares , Ligação Proteica , Receptores de Estrogênio/metabolismo , Tiazinas/síntese química , Ativação Transcricional/efeitos dos fármacos , Células Tumorais Cultivadas/efeitos dos fármacosRESUMO
The synthesis of two novel radiolabelled estrogen derivatives, [125I](E)-3-methoxy-17alpha-iodovinylestra-1,3,5(10),6-tetraen-17beta-ol (E[125I]IVDE) and [125I](Z)-3-methoxy-17alpha-iodovinylestra-1,3,5(10),6-tetraen-17beta-ol (Z[125I]IVDE), was carried out aiming to study the influence of the introduction of a C6-C7 double bond on the biological properties of the estradiol molecule. 3-Methoxyestra-1,3,5(10),6-tetraen-17-one was synthesised starting from a suitably protected estrone and subsequently converted into the 17alpha-ethynyl derivative. The radioiodinated derivatives were stereoselectively formed by radioiododestannylation of the corresponding tributylstannyl precursors. The biodistribution of the novel [125I]iodovinylestradiol derivatives was evaluated in immature female mice. Biological data indicated that the Z-isomer, owing to its higher in vivo uptake by the target tissue, has the preferable configuration for further development of similar compounds for estrogen receptor detection.
Assuntos
Congêneres do Estradiol/síntese química , Congêneres do Estradiol/farmacocinética , Estradiol/análogos & derivados , Estradiol/síntese química , Estradiol/farmacocinética , Animais , Neoplasias da Mama/diagnóstico por imagem , Neoplasias da Mama/metabolismo , Feminino , Humanos , Radioisótopos do Iodo , Camundongos , Cintilografia , Receptores de Estrogênio/metabolismo , Estereoisomerismo , Distribuição Tecidual , Útero/metabolismoRESUMO
To improve the ratio of non-hormonal to hormonal activity, estrogens 3 and 4 were modified at various molecule positions. Isomerization of the 14 alpha,15 alpha-methylene bridge, controlled 3-methoxy group cleavage with respect to the 14 alpha,15 alpha-methylene bridge stereochemistry, reduction of the 8-double bond, and substitution of the oxyfunctionality at C-17 by a methylene and a difluoromethylene moiety were in the focus. As a result of in vivo and in vitro tests, compounds 27 and 29 were selected as potential follow-up candidates of lead 3.